Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tenax Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +3 vs. Q3 2021
- Shares held
- 8.06M
- +350.8K (+4.5%) vs. Q3 2021
- Total value
- $8.38M
- −$5.26M (−38.6%) vs. Q3 2021
- New holders
- 5
- 6 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gofen & Glossberg LLC | 3,819,170 | $3.97M | 0.09% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,019,995 | $2.10M | 0.05% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 694,195 | $722.0K | 0.21% | +227,934+48.9% | Added |
| BlackRock Inc. | 512,284 | $533.0K | 0.00% | +870+0.2% | Added |
| Vanguard Group Inc | 360,069 | $374.0K | 0.00% | −3,000−0.8% | Reduced |
| The PNC Financial Services Group, Inc. | 200,000 | $208.0K | 0.00% | +130,000+185.7% | Added |
| State Street Corp | 136,404 | $142.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 80,432 | $84.0K | 0.00% | −22,500−21.9% | Reduced |
| Boothbay Fund Management, LLC | 71,808 | $75.0K | 0.00% | +25,277+54.3% | Added |
| Financial Advisory Service, Inc. | 58,326 | $61.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 51,212 | $53.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 34,671 | $36.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 13,268 | $13.0K | 0.00% | +13,268 | New |
| Tower Research Capital LLC (TRC) | 4,745 | $5.00K | 0.00% | +4,735+47,350.0% | Added |
| UBS Group AG | 4,811 | $5.00K | 0.00% | +4,770+11,634.1% | Added |
| Banque Cantonale Vaudoise | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 27 | $0 | 0.00% | −73−73.0% | Reduced |
| Wells Fargo & Company | 92 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Planning LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 10 | $0 | 0.00% | +10 | New |
| Captrust Financial Advisors | 2 | $0 | 0.00% | +2 | New |
| Horan Securities, Inc. | 1 | $0 | 0.00% | +1 | New |
| Confluence Wealth Services, Inc. | 100 | $0 | 0.00% | +100 | New |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −30,600−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |